{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:33:32Z","timestamp":1774510412822,"version":"3.50.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,25]]},"DOI":"10.7759\/cureus.105862","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:35:36Z","timestamp":1774503336000},"source":"Crossref","is-referenced-by-count":0,"title":["Longitudinally Extensive Transverse Myelitis in Autoimmune Connective Tissue Diseases: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Guhan S","family":"R","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Namasivayam","family":"K","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nerep.2025.100255","article-title":"Longitudinally extensive transverse myelitis: etiologies and common diagnostic pitfalls","volume":"7","author":"Abbas SA","year":"2025","unstructured":"Abbas SA, Costa J, Saba J, Matta C, Abboud H. Longitudinally extensive transverse myelitis: etiologies and common diagnostic pitfalls. Neuroimmunol Rep. 2025, 7:100255. 10.1016\/j.nerep.2025.100255","journal-title":"Neuroimmunol Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.crad.2016.05.020","article-title":"Evaluation and management of longitudinally extensive transverse myelitis: a guide for radiologists","volume":"71","author":"Mirbagheri S","year":"2016","unstructured":"Mirbagheri S, Eckart Sorte D, Zamora CA, Mossa-Basha M, Newsome SD, Izbudak I. Evaluation and management of longitudinally extensive transverse myelitis: a guide for radiologists. Clin Radiol. 2016, 71:960-71. 10.1016\/j.crad.2016.05.020","journal-title":"Clin Radiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2020.08.003","article-title":"Acute and subacute myelopathy","volume":"177","author":"Marignier R","year":"2021","unstructured":"Marignier R. Acute and subacute myelopathy. Rev Neurol (Paris). 2021, 177:557-66. 10.1016\/j.neurol.2020.08.003","journal-title":"Rev Neurol (Paris)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-016-0742-y","article-title":"Etiologic spectrum and functional outcome of the acute inflammatory myelitis","volume":"117","author":"Carnero Contentti E","year":"2017","unstructured":"Carnero Contentti E, Hryb JP, Diego A, Di Pace JL, Perassolo M. Etiologic spectrum and functional outcome of the acute inflammatory myelitis. Acta Neurol Belg. 2017, 117:507-13. 10.1007\/s13760-016-0742-y","journal-title":"Acta Neurol Belg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky DS","year":"2023","unstructured":"Pisetsky DS. Pathogenesis of autoimmune disease. Nat Rev Nephrol. 2023, 19:509-24. 10.1038\/s41581-023-00720-1","journal-title":"Nat Rev Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: translating evidence into policy","volume":"19","author":"Feigin VL","year":"2020","unstructured":"Feigin VL, Vos T, Nichols E, et al.. The global burden of neurological disorders: translating evidence into policy. Lancet Neurol. 2020, 19:255-65. 10.1016\/S1474-4422(19)30411-9","journal-title":"Lancet Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.47108","article-title":"Neurological manifestations of connective tissue disorders","volume":"15","author":"Poshattiwar RS","year":"2023","unstructured":"Poshattiwar RS, Acharya S, Shukla S, Kumar S. Neurological manifestations of connective tissue disorders. Cureus. 2023, 15:e47108. 10.7759\/cureus.47108","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2011.176","article-title":"Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica","volume":"7","author":"Trebst C","year":"2011","unstructured":"Trebst C, Raab P, Voss EV, Rommer P, Abu-Mugheisib M, Zettl UK, Stangel M. Longitudinal extensive transverse myelitis--it's not all neuromyelitis optica. Nat Rev Neurol. 2011, 7:688-98. 10.1038\/nrneurol.2011.176","journal-title":"Nat Rev Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-03935-y","article-title":"Myelopathy associated with mixed connective tissue disease: clinical manifestation, diagnosis, treatment, and prognosis","volume":"40","author":"Hao Y","year":"2019","unstructured":"Hao Y, Xin M, Wang S, Ma D, Feng J. Myelopathy associated with mixed connective tissue disease: clinical manifestation, diagnosis, treatment, and prognosis. Neurol Sci. 2019, 40:1785-97. 10.1007\/s10072-019-03935-y","journal-title":"Neurol Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.998328","article-title":"Pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus: a review","volume":"10","author":"Liu Y","year":"2022","unstructured":"Liu Y, Tu Z, Zhang X, Du K, Xie Z, Lin Z. Pathogenesis and treatment of neuropsychiatric systemic lupus erythematosus: a review. Front Cell Dev Biol. 2022, 10:998328. 10.3389\/fcell.2022.998328","journal-title":"Front Cell Dev Biol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2021.07.148","article-title":"Inflammatory response to spinal cord injury and its treatment","volume":"155","author":"Liu X","year":"2021","unstructured":"Liu X, Zhang Y, Wang Y, Qian T. Inflammatory response to spinal cord injury and its treatment. World Neurosurg. 2021, 155:19-31. 10.1016\/j.wneu.2021.07.148","journal-title":"World Neurosurg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.684699","article-title":"Interstitial lung disease in connective tissue disease: a common lesion with heterogeneous mechanisms and treatment considerations","volume":"12","author":"Shao T","year":"2021","unstructured":"Shao T, Shi X, Yang S, et al.. Interstitial lung disease in connective tissue disease: a common lesion with heterogeneous mechanisms and treatment considerations. Front Immunol. 2021, 12:684699. 10.3389\/fimmu.2021.684699","journal-title":"Front Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1590\/S1679-45082015RW3308","article-title":"An update of neurological manifestations of vasculitides and connective tissue diseases: a literature review","volume":"13","author":"Bougea A","year":"2015","unstructured":"Bougea A, Anagnostou E, Spandideas N, Triantafyllou N, Kararizou E. An update of neurological manifestations of vasculitides and connective tissue diseases: a literature review. Einstein (Sao Paulo). 2015, 13:627-35. 10.1590\/S1679-45082015RW3308","journal-title":"Einstein (Sao Paulo)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.sult.2016.05.004","article-title":"Transverse myelitis and neuromyelitis optica spectrum disorders","volume":"37","author":"Young V","year":"2016","unstructured":"Young V, Quaghebeur G. Transverse myelitis and neuromyelitis optica spectrum disorders. Semin Ultrasound CT MR. 2016, 37:384-95. 10.1053\/j.sult.2016.05.004","journal-title":"Semin Ultrasound CT MR"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00543-w","article-title":"Autoantibodies in neurological disease","volume":"21","author":"Pr\u00fcss H","year":"2021","unstructured":"Pr\u00fcss H. Autoantibodies in neurological disease. Nat Rev Immunol. 2021, 21:798-813. 10.1038\/s41577-021-00543-w","journal-title":"Nat Rev Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1485799","article-title":"Harnessing artificial intelligence for the diagnosis and treatment of neurological emergencies: a comprehensive review of recent advances and future directions","volume":"15","author":"AbuAlrob MA","year":"2024","unstructured":"AbuAlrob MA, Mesraoua B. Harnessing artificial intelligence for the diagnosis and treatment of neurological emergencies: a comprehensive review of recent advances and future directions. Front Neurol. 2024, 15:1485799. 10.3389\/fneur.2024.1485799","journal-title":"Front Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04429-y","article-title":"Different clinical characteristics of longitudinally extensive transverse myelitis with and without connective tissue disorders: a single-center retrospective study","volume":"41","author":"Zhang QX","year":"2020","unstructured":"Zhang QX, Huang CN, Zhang LJ, et al.. Different clinical characteristics of longitudinally extensive transverse myelitis with and without connective tissue disorders: a single-center retrospective study. Neurol Sci. 2020, 41:2859-66. 10.1007\/s10072-020-04429-y","journal-title":"Neurol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.4037\/ajcc2005.14.2.109","article-title":"Adjunctive use of plasmapheresis and intravenous immunoglobulin therapy in sepsis: a case report","volume":"14","author":"Kyles DM","year":"2005","unstructured":"Kyles DM, Baltimore J. Adjunctive use of plasmapheresis and intravenous immunoglobulin therapy in sepsis: a case report. Am J Crit Care. 2005, 14:109-12. 10.4037\/ajcc2005.14.2.109","journal-title":"Am J Crit Care"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-012-0172-y","article-title":"Complications of immunosuppressive\/immunomodulatory therapy in neurological diseases","volume":"14","author":"Nath A","year":"2012","unstructured":"Nath A, Berger JR. Complications of immunosuppressive\/immunomodulatory therapy in neurological diseases. Curr Treat Options Neurol. 2012, 14:241-55. 10.1007\/s11940-012-0172-y","journal-title":"Curr Treat Options Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106764","article-title":"Longitudinally extensive transverse myelitis in childhood: clinical features, treatment approaches, and long-term neurological outcomes","volume":"207","author":"Celik H","year":"2021","unstructured":"Celik H, Aksoy E, Oztoprak U, et al.. Longitudinally extensive transverse myelitis in childhood: clinical features, treatment approaches, and long-term neurological outcomes. Clin Neurol Neurosurg. 2021, 207:106764. 10.1016\/j.clineuro.2021.106764","journal-title":"Clin Neurol Neurosurg"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(24)00256-4","article-title":"Differential diagnosis of suspected multiple sclerosis: global health considerations","volume":"23","author":"Correale J","year":"2024","unstructured":"Correale J, Solomon AJ, Cohen JA, et al.. Differential diagnosis of suspected multiple sclerosis: global health considerations. Lancet Neurol. 2024, 23:1035-49. 10.1016\/S1474-4422(24)00256-4","journal-title":"Lancet Neurol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.82062","article-title":"Decoding autoimmunity: insights into neuromyelitis optica and its relationship with other autoimmune neurological disorders","volume":"17","author":"Siddiqui TW","year":"2025","unstructured":"Siddiqui TW, Siddiqui RW, Siddiqui SW, et al.. Decoding autoimmunity: insights into neuromyelitis optica and its relationship with other autoimmune neurological disorders. Cureus. 2025, 17:e82062. 10.7759\/cureus.82062","journal-title":"Cureus"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11111956","article-title":"Clinical manifestations, pathogenesis, diagnosis and treatment of peripheral neuropathies in connective tissue diseases: more diverse and frequent in different subtypes than expected","volume":"11","author":"Jin L","year":"2021","unstructured":"Jin L, Liu Y. Clinical manifestations, pathogenesis, diagnosis and treatment of peripheral neuropathies in connective tissue diseases: more diverse and frequent in different subtypes than expected. Diagnostics (Basel). 2021, 11:10.3390\/diagnostics11111956","journal-title":"Diagnostics (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.radcr.2020.06.001","article-title":"Acute myelitis as a neurological complication of Covid-19: a case report and MRI findings","volume":"15","author":"AlKetbi R","year":"2020","unstructured":"AlKetbi R, AlNuaimi D, AlMulla M, AlTalai N, Samir M, Kumar N, AlBastaki U. Acute myelitis as a neurological complication of Covid-19: a case report and MRI findings. Radiol Case Rep. 2020, 15:1591-5. 10.1016\/j.radcr.2020.06.001","journal-title":"Radiol Case Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/09612033231185612","article-title":"Transverse myelitis associated with systemic lupus erythematosus (SLE-TM): a review article","volume":"32","author":"Jain S","year":"2023","unstructured":"Jain S, Khormi A, Sangle SR, D'Cruz DP. Transverse myelitis associated with systemic lupus erythematosus (SLE-TM): a review article. Lupus. 2023, 32:1033-42. 10.1177\/09612033231185612","journal-title":"Lupus"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11030675","article-title":"Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: a comprehensive review","volume":"11","author":"Alijotas-Reig J","year":"2022","unstructured":"Alijotas-Reig J, Esteve-Valverde E, Anunciaci\u00f3n-Llunell A, Marques-Soares J, Pardos-Gea J, Mir\u00f3-Mur F. Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: a comprehensive review. J Clin Med. 2022, 11:10.3390\/jcm11030675","journal-title":"J Clin Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26157101","article-title":"Understanding sex differences in autoimmune diseases: immunologic mechanisms","volume":"26","author":"Kim YR","year":"2025","unstructured":"Kim YR, Jung Y, Kang I, Yeo EJ. Understanding sex differences in autoimmune diseases: immunologic mechanisms. Int J Mol Sci. 2025, 26:10.3390\/ijms26157101","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.06.008","article-title":"Sex bias and autoimmune diseases","volume":"142","author":"Xing E","year":"2022","unstructured":"Xing E, Billi AC, Gudjonsson JE. Sex bias and autoimmune diseases. J Invest Dermatol. 2022, 142:857-66. 10.1016\/j.jid.2021.06.008","journal-title":"J Invest Dermatol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2019.102423","article-title":"Comparative United States autoimmune disease rates for 2010-2016 by sex, geographic region, and race","volume":"19","author":"Roberts MH","year":"2020","unstructured":"Roberts MH, Erdei E. Comparative United States autoimmune disease rates for 2010-2016 by sex, geographic region, and race. Autoimmun Rev. 2020, 19:102423. 10.1016\/j.autrev.2019.102423","journal-title":"Autoimmun Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian J","year":"2023","unstructured":"Tian J, Zhang D, Yao X, Huang Y, Lu Q. Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis. 2023, 82:351-6. 10.1136\/ard-2022-223035","journal-title":"Ann Rheum Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.2315","article-title":"Systemic lupus erythematosus: a review","volume":"331","author":"Siegel CH","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024, 331:1480-91. 10.1001\/jama.2024.2315","journal-title":"JAMA"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2016.00098","article-title":"Inflammogenesis of secondary spinal cord injury","volume":"10","author":"Anwar MA","year":"2016","unstructured":"Anwar MA, Al Shehabi TS, Eid AH. Inflammogenesis of secondary spinal cord injury. Front Cell Neurosci. 2016, 10:98. 10.3389\/fncel.2016.00098","journal-title":"Front Cell Neurosci"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2025.1634127","article-title":"Clinical features and prognosis of NMOSD patients with positive autoimmune antibodies","volume":"16","author":"Liu Y","year":"2025","unstructured":"Liu Y, Liu Y, Yuan H, Wang L. Clinical features and prognosis of NMOSD patients with positive autoimmune antibodies. Front Neurol. 2025, 16:1634127. 10.3389\/fneur.2025.1634127","journal-title":"Front Neurol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103103","article-title":"Transverse myelitis in systemic lupus erythematosus: a case report and systematic literature review","volume":"21","author":"Wen X","year":"2022","unstructured":"Wen X, Xu D, Yuan S, Zhang J. Transverse myelitis in systemic lupus erythematosus: a case report and systematic literature review. Autoimmun Rev. 2022, 21:103103. 10.1016\/j.autrev.2022.103103","journal-title":"Autoimmun Rev"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1177\/19714009231187340","article-title":"Autoimmune diseases of the spine and spinal cord","volume":"37","author":"Biddle G","year":"2024","unstructured":"Biddle G, Beck RT, Raslan O, et al.. Autoimmune diseases of the spine and spinal cord. Neuroradiol J. 2024, 37:285-303. 10.1177\/19714009231187340","journal-title":"Neuroradiol J"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200329","article-title":"\u201cLupus myelitis\u201d revisited: a retrospective single-center study of myelitis associated with rheumatologic disease","volume":"12","author":"Krett JD","year":"2025","unstructured":"Krett JD, Filippatou AG, Barreras P, Pardo CA, Gelber AC, Sotirchos ES. \u201cLupus myelitis\u201d revisited: a retrospective single-center study of myelitis associated with rheumatologic disease. Neurol Neuroimmunol Neuroinflamm. 2025, 12:e200329. 10.1212\/NXI.0000000000200329","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbre.2016.03.006","article-title":"Myelopathy in systemic lupus erythematosus: clinical, laboratory, radiological and progression findings in a cohort of 1,193 patients","volume":"56","author":"Costallat BL","year":"2016","unstructured":"Costallat BL, Ferreira DM, Costallat LT, Appenzeller S. Myelopathy in systemic lupus erythematosus: clinical, laboratory, radiological and progression findings in a cohort of 1,193 patients. Rev Bras Reumatol Engl Ed. 2016, 56:240-51. 10.1016\/j.rbre.2016.03.006","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2014.11.014","article-title":"Longitudinally extensive transverse myelitis in systemic lupus erythematosus: case report and review of the literature","volume":"129","author":"Nardone R","year":"2015","unstructured":"Nardone R, Fitzgerald RT, Bailey A, Zuccoli G. Longitudinally extensive transverse myelitis in systemic lupus erythematosus: case report and review of the literature. Clin Neurol Neurosurg. 2015, 129:57-61. 10.1016\/j.clineuro.2014.11.014","journal-title":"Clin Neurol Neurosurg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2025.106279","article-title":"Longitudinally extensive transverse myelitis: impact on functional prognosis and mortality in a 10-year follow-up cohort","volume":"94","author":"Silva PB","year":"2025","unstructured":"Silva PB, Ap\u00f3stolos Pereira SL, Aguiar G, et al.. Longitudinally extensive transverse myelitis: impact on functional prognosis and mortality in a 10-year follow-up cohort. Mult Scler Relat Disord. 2025, 94:106279. 10.1016\/j.msard.2025.106279","journal-title":"Mult Scler Relat Disord"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.31083\/j.jin2302035","article-title":"Systemic connective tissue disease and neuromyelitis optica spectrum disorder coexistence: a systematic review and meta-analysis","volume":"23","author":"Esposito JE","year":"2024","unstructured":"Esposito JE, Annoni G, D'Amato M, et al.. Systemic connective tissue disease and neuromyelitis optica spectrum disorder coexistence: a systematic review and meta-analysis. J Integr Neurosci. 2024, 23:35. 10.31083\/j.jin2302035","journal-title":"J Integr Neurosci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.31334","article-title":"Autoimmune myelitis and myocarditis in a patient with anti-aquaporin-4, antinuclear, and antiphospholipid autoantibodies: the neuromyelitis optica-systemic lupus erythematosus (NMO-SLE) overlap syndrome","volume":"14","author":"Mader EC Jr","year":"2022","unstructured":"Mader EC Jr, Verdecie O, Losada V, Lovera JF. Autoimmune myelitis and myocarditis in a patient with anti-aquaporin-4, antinuclear, and antiphospholipid autoantibodies: the neuromyelitis optica-systemic lupus erythematosus (NMO-SLE) overlap syndrome. Cureus. 2022, 14:e31334. 10.7759\/cureus.31334","journal-title":"Cureus"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2022-249915","article-title":"Myelin oligodendrocyte glycoprotein (MOG) antibody-associated longitudinally extensive transverse myelitis (LETM) and primary Sjogren syndrome: a rare association","volume":"15","author":"Sahoo D","year":"2022","unstructured":"Sahoo D, Dash A, Dey A, Devi S. Myelin oligodendrocyte glycoprotein (MOG) antibody-associated longitudinally extensive transverse myelitis (LETM) and primary Sjogren syndrome: a rare association. BMJ Case Rep. 2022, 15:10.1136\/bcr-2022-249915","journal-title":"BMJ Case Rep"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14153","article-title":"Systemic sclerosis","volume":"45","author":"Asano Y","year":"2018","unstructured":"Asano Y. Systemic sclerosis. J Dermatol. 2018, 45:128-38. 10.1111\/1346-8138.14153","journal-title":"J Dermatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.nerep.2021.100051","article-title":"Acute hemorrhagic longitudinally extensive transverse myelitis: a case report and review of the literature","volume":"2","author":"Howard CW","year":"2022","unstructured":"Howard CW, Racosta JM, Robinson DB. Acute hemorrhagic longitudinally extensive transverse myelitis: a case report and review of the literature. Neuroimmunol Rep. 2022, 2:100051. 10.1016\/j.nerep.2021.100051","journal-title":"Neuroimmunol Rep"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.13968","article-title":"Longitudinally extensive transverse myelitis: a retrospective study differentiating neuromyelitis optica spectrum disorder from other etiologies","volume":"13","author":"Paudel S","year":"2021","unstructured":"Paudel S, Nepal G, Guragain S, et al.. Longitudinally extensive transverse myelitis: a retrospective study differentiating neuromyelitis optica spectrum disorder from other etiologies. Cureus. 2021, 13:e13968. 10.7759\/cureus.13968","journal-title":"Cureus"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2025-0390.PV297","article-title":"Mixed connective tissue disease evolving from the sequential overlap of systemic lupus erythematosus, Sj\u00f6gren\u2019s syndrome, rheumatoid arthritis and dermatomyositis: a follow-up","volume":"52","author":"Cheng JC","year":"2025","unstructured":"Cheng JC, Ang DK, Cheng AN, Tan E, Vista EG. Mixed connective tissue disease evolving from the sequential overlap of systemic lupus erythematosus, Sj\u00f6gren\u2019s syndrome, rheumatoid arthritis and dermatomyositis: a follow-up. J Rheumatol. 2025, 52:264-73. 10.3899\/jrheum.2025-0390.PV297","journal-title":"J Rheumatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.12.033","article-title":"Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity","volume":"373","author":"Carnero Contentti E","year":"2017","unstructured":"Carnero Contentti E, Hryb JP, Morales S, et al.. Longitudinally extensive transverse myelitis immune-mediated in aquaporin-4 antibody negative patients: Disease heterogeneity. J Neurol Sci. 2017, 373:134-7. 10.1016\/j.jns.2016.12.033","journal-title":"J Neurol Sci"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.4103\/jfmpc.jfmpc_2101_20","article-title":"Tubercular longitudinally extensive transverse myelitis (LETM): an enigma for primary care physicians","volume":"10","author":"Anand KA","year":"2021","unstructured":"Anand KA, Bhowmik KK, Sarkar A, Ghosh R, Mandal A, Swaika B, Ray BK. Tubercular longitudinally extensive transverse myelitis (LETM): an enigma for primary care physicians. J Family Med Prim Care. 2021, 10:1057-60. 10.4103\/jfmpc.jfmpc_2101_20","journal-title":"J Family Med Prim Care"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcl.2013.11.002","article-title":"Imaging approach to the cord T2 hyperintensity (myelopathy)","volume":"52","author":"Grayev AM","year":"2014","unstructured":"Grayev AM, Kissane J, Kanekar S. Imaging approach to the cord T2 hyperintensity (myelopathy). Radiol Clin North Am. 2014, 52:427-46. 10.1016\/j.rcl.2013.11.002","journal-title":"Radiol Clin North Am"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.nerep.2022.100090","article-title":"Persistent spinal cord enhancement in longitudinal extensive transverse myelitis associated with \u03b1-1-antitrypsin deficiency: a case report","volume":"2","author":"Ozel O","year":"2022","unstructured":"Ozel O, Eckert SP, Jakimovski D, Silvestri N, Hojnacki D, Weinstock-Guttman B. Persistent spinal cord enhancement in longitudinal extensive transverse myelitis associated with \u03b1-1-antitrypsin deficiency: a case report. Neuroimmunol Rep. 2022, 2:100090. 10.1016\/j.nerep.2022.100090","journal-title":"Neuroimmunol Rep"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-021-01723-0","article-title":"Longitudinally extensive transverse myelitis with mycobacterium tuberculosis infection","volume":"123","author":"Fang L","year":"2023","unstructured":"Fang L, Gong Y, Han K, Lv Y, Li M, Wang J. Longitudinally extensive transverse myelitis with mycobacterium tuberculosis infection. Acta Neurol Belg. 2023, 123:243-6. 10.1007\/s13760-021-01723-0","journal-title":"Acta Neurol Belg"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30138-3","article-title":"MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers","volume":"18","author":"Freund P","year":"2019","unstructured":"Freund P, Seif M, Weiskopf N, Friston K, Fehlings MG, Thompson AJ, Curt A. MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers. Lancet Neurol. 2019, 18:1123-35. 10.1016\/S1474-4422(19)30138-3","journal-title":"Lancet Neurol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.4103\/aian.aian_1054_21","article-title":"Central nervous system and systemic autoimmune disease: coexistence or more?","volume":"25","author":"Vibha D","year":"2022","unstructured":"Vibha D, Singh RK. Central nervous system and systemic autoimmune disease: coexistence or more?. Ann Indian Acad Neurol. 2022, 25:181-2. 10.4103\/aian.aian_1054_21","journal-title":"Ann Indian Acad Neurol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102996","article-title":"Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: a systematic review and meta-analysis","volume":"21","author":"Wang M","year":"2022","unstructured":"Wang M, Wang Z, Zhang S, et al.. Relapse rates and risk factors for unfavorable neurological prognosis of transverse myelitis in systemic lupus erythematosus: a systematic review and meta-analysis. Autoimmun Rev. 2022, 21:102996. 10.1016\/j.autrev.2021.102996","journal-title":"Autoimmun Rev"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqz142","article-title":"Erythrocyte sedimentation rate and C-reactive protein in acute inflammation","volume":"153","author":"Lapi\u0107 I","year":"2020","unstructured":"Lapi\u0107 I, Padoan A, Bozzato D, Plebani M. Erythrocyte sedimentation rate and C-reactive protein in acute inflammation. Am J Clin Pathol. 2020, 153:14-29. 10.1093\/ajcp\/aqz142","journal-title":"Am J Clin Pathol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2019.03.002","article-title":"Diagnostic value of oligoclonal bands in children: a nationwide population-based cohort study","volume":"97","author":"Boesen MS","year":"2019","unstructured":"Boesen MS, Born AP, Jensen PE, et al.. Diagnostic value of oligoclonal bands in children: a nationwide population-based cohort study. Pediatr Neurol. 2019, 97:56-63. 10.1016\/j.pediatrneurol.2019.03.002","journal-title":"Pediatr Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/463413-longitudinally-extensive-transverse-myelitis-in-autoimmune-connective-tissue-diseases-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T05:35:37Z","timestamp":1774503337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/463413-longitudinally-extensive-transverse-myelitis-in-autoimmune-connective-tissue-diseases-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,25]]},"references-count":56,"URL":"https:\/\/doi.org\/10.7759\/cureus.105862","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,25]]}}}